1. Market Research
  2. > Pathology Industry

anemia Industry, September 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, Blood Disease, Injectable Delivery, Clinical Trial, In Vitro Diagnostic Reagent, Therapy, Endocrine Disease, Autoimmune Disease, Biosimilar, Erythropoietin, Bone Marrow Transplant, Point Of Care Testing, Cancer, Digestive System Disorder, Prefillable Syringe.


 
1-10 of 80 reports for anemia

Purchase Reports From Reputable Market Research Publishers

Global Anemia Partnering 2010 to 2016

Global Anemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed ...

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Renal Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • September 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

About 6 200 reports for anemia

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics in the Netherlands

  • September 2016
    184 pages
  • Blood Disease  

  • Netherlands  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.